Quinolynylmethylimidizoles as therapeutic agents

Details for Australian Patent Application No. 2009246601 (hide)

Owner Allergan, Inc.

Inventors Heidelbaugh, Todd M.; Chow, Ken; Nguyen, Phong X.; Garst, Michael E.

Agent Davies Collison Cave

Pub. Number AU-A-2009246601

PCT Pub. Number WO2009/140138

Priority 61/052,778 13.05.08 US

Filing date 7 May 2009

Wipo publication date 19 November 2009

International Classifications

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/140138 Priority application(s): WO2009/140138

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246603-von Willebrand Factor (VWF) inhibitors for treatment or prevention of infarction

2009246600-Naphthylmethylimidizoles for the treatment of stress urinary incontinence